✦ LIBER ✦

Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial

✍ Scribed by Robert Benamouzig; Jacques Deyra; Antoine Martin; Bernard Girard; Eric Jullian; Benoit Piednoir; Daniel Couturier; Thierry Coste; Julian Little; Stanislas Chaussade

Book ID: 119426668
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 132 KB
Volume: 125
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(03)00887-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention by daily soluble aspirin of c

Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial

✍ Benamouzig, R.; Uzzan, B.; Deyra, J.; Martin, A.; Girard, B.; Little, J.; Chauss 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 153 KB

Prevention by Aspirin of Colorectal Aden

Prevention by Aspirin of Colorectal Adenoma Recurrence: Some Advances and Latest Results of the APACC Trial

✍ Robert Benamouzig; Bernard Uzzan; Jacques Deyra; Antoine Martin; Stanislas Chaus 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 273 KB

Aspirin and Folic Acid for the Preventio

Aspirin and Folic Acid for the Prevention of Recurrent Colorectal Adenomas

✍ Richard F.A. Logan; Matthew J. Grainge; Vic C. Shepherd; Nicholas C. Armitage; K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 520 KB

Calcium and fibre supplementation in pre

Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial

✍ Claire Bonithon-Kopp; Ole Kronborg; Attilio Giacosa; Ulrich Räth; Jean Faivre 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 107 KB

M1177 Risk of Colorectal Adenoma Recurre

M1177 Risk of Colorectal Adenoma Recurrence Due to Red Blood Cell Folate Level in the Post Folate Fortification Era: Results From the Adenoma Prevention With Celecoxib (APC) Trial

✍ Chou, Joanne F.; Eslick, Guy D.; Vitolins, Mara Z.; Tooze, Janet A.; Bacher, Jas 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Polymorphisms in PTGS1, PTGS2 and IL-10

Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial

✍ Richard A. Hubner; Kenneth R. Muir; Jo-Fen Liu; Richard F.A. Logan; Matthew J. G 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 74 KB

## Abstract Regular use of aspirin and other nonsteroidal antiinflammatory drugs reduces both the development of colorectal neoplasia and recurrence of colorectal adenoma (CRA). Modulation of the effects of aspirin by genetic factors has been reported, potentially allowing targeting of treatment to